Contribution of STAT3 to the pathogenesis of COVID-19

被引:74
作者
Jafarzadeh, Abdollah [1 ,2 ]
Nemati, Maryam [3 ,4 ]
Jafarzadeh, Sara [5 ]
机构
[1] Kerman Univ Med Sci, Sch Med, Dept Immunol, Kerman, Iran
[2] Rafsanjan Univ Med Sci, Sch Med, Dept Immunol, Rafsanjan, Iran
[3] Rafsanjan Univ Med Sci, Immunol Infect Dis Res Ctr, Res Inst Basic Med Sci, Rafsanjan, Iran
[4] Kerman Univ Med Sci, Sch Paramed, Dept Hematol & Lab Sci, Kerman, Iran
[5] Kerman Univ Med Sci, Sch Med, Student Res Comm, Kerman, Iran
关键词
COVID-19; SARS-CoV-2; STAT3; Pathogenesis; Inflammation; Immune response; Treatment; IL-6; DIFFERENTIATION; INTERLEUKIN-6; INFLAMMATION; ACTIVATION; PROTEIN; INJURY;
D O I
10.1016/j.micpath.2021.104836
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hyper-inflammatory responses, lymphopenia, unbalanced immune responses, cytokine storm, large viral replication and massive cell death play fundamental roles in the pathogenesis of COVID-19. Extreme production of many kinds of pro-inflammatory cytokines and chemokines occur in severe COVID-19 that called cytokine storm. Signal transducer and activator of transcription-3 (STAT-3) present in the cytoplasm in an inactive form and can be stimulated by a vast range of cytokines, chemokines and growth factors. Thus, STAT-3 can participate in the induction of inflammatory responses during coronavirus infections. STAT-3 can also suppress anti-virus interferon response and induce unbalanced anti-virus adaptive immune response, through influencing Th17-, Th1-, Treg-, and B cell-mediated functions. Furthermore, STAT-3 can contribute to the M2 macrophage polarization, lung fibrosis and thrombosis. Moreover, STAT-3 may be directly targeted by some virus-derived protein and operate as a pro-viral or anti-viral element in a virus-specific process. Here, the possible contribution of STAT-3 to the pathogenesis of COVID-19 was explained, while providing potential approaches to target this transcription factor in an attempt for COVID-19 treatment.
引用
收藏
页数:8
相关论文
共 112 条
[61]   A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections [J].
Orlov, Marika ;
Wander, Pandora L. ;
Morrell, Eric D. ;
Mikacenic, Carmen ;
Wurfel, Mark M. .
JOURNAL OF IMMUNOLOGY, 2020, 205 (04) :892-898
[62]   Differential Signaling and Virus Production in Calu-3 Cells and Vero Cells upon SARS-CoV-2 Infection [J].
Park, Byoung Kwon ;
Kim, Dongbum ;
Park, Sangkyu ;
Maharjan, Sony ;
Kim, Jinsoo ;
Choi, Jun-Kyu ;
Akauliya, Madhav ;
Lee, Younghee ;
Kwon, Hyung-Joo .
BIOMOLECULES & THERAPEUTICS, 2021, 29 (03) :273-281
[63]   SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells [J].
Patra, Tapas ;
Meyer, Keith ;
Geerling, Lizzie ;
Isbell, T. Scott ;
Hoft, Daniel F. ;
Brien, James ;
Pinto, Amelia K. ;
Ray, Ratna B. ;
Ray, Ranjit .
PLOS PATHOGENS, 2020, 16 (12)
[64]   STAT3-Mediated Signaling Dysregulates Lung Fibroblast-Myofibroblast Activation and Differentiation in UIP/IPF [J].
Pechkovsky, Dmitri V. ;
Prele, Cecilia M. ;
Wong, John ;
Hogaboam, Cory M. ;
McAnulty, Robin J. ;
Laurent, Geoffrey J. ;
Zhang, Samuel S. -M. ;
Selman, Moises ;
Mutsaers, Steven E. ;
Knight, Darryl A. .
AMERICAN JOURNAL OF PATHOLOGY, 2012, 180 (04) :1398-1412
[65]   STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation [J].
Pedroza, Mesias ;
Le, Thuy T. ;
Lewis, Katherine ;
Karmouty-Quintana, Harry ;
To, Sarah ;
George, Anuh T. ;
Blackburn, Michael R. ;
Tweardy, David J. ;
Agarwal, Sandeep K. .
FASEB JOURNAL, 2016, 30 (01) :129-140
[66]   Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology [J].
Pyle, Chloe J. ;
Uwadiae, Faith I. ;
Swieboda, David P. ;
Harker, James A. .
PLOS PATHOGENS, 2017, 13 (09)
[67]   Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China [J].
Qin, Chuan ;
Zhou, Luoqi ;
Hu, Ziwei ;
Zhang, Shuoqi ;
Yang, Sheng ;
Tao, Yu ;
Xie, Cuihong ;
Ma, Ke ;
Shang, Ke ;
Wang, Wei ;
Tian, Dai-Shi .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (15) :762-768
[68]   The COVID-19 Cytokine Storm; What We Know So Far [J].
Ragab, Dina ;
Salah Eldin, Haitham ;
Taeimah, Mohamed ;
Khattab, Rasha ;
Salem, Ramy .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[69]   Signals of Th2 immune response from COVID-19 patients requiring intensive care [J].
Roncati, Luca ;
Nasillo, Vincenzo ;
Lusenti, Beatrice ;
Riva, Giovanni .
ANNALS OF HEMATOLOGY, 2020, 99 (06) :1419-1420
[70]  
Sang Yongming, 2015, J Clin Cell Immunol, V6